Inicia sesión Registrate Mi Biblioteca biblioteca abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

Tratamiento no farmacológico

490 ARTíCULOS , VIENDO DEL 361 AL 375

PUBMED

The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review

Zhang S, Zhu Q, Chen JY, OuYang D, Lu JH.

Phytomedicine. 2020 Dec;79:153316. doi: 10.1016/j.phymed.2020.153316. Epub 2020 Aug 31.

0

0

0

PUBMED

Targetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer's Disease

Yin Q, Ji X, Lv R, Pei JJ, Du Y, Shen C, Hou X.

Clin Interv Aging. 2020 Feb 13;15:195-205. doi: 10.2147/CIA.S240400. eCollection 2020.

0

0

0

PUBMED

Delaying memory decline: different options and emerging solutions

Schneider F, Horowitz A, Lesch KP, Dandekar T.

Transl Psychiatry. 2020 Jan 21;10(1):13. doi: 10.1038/s41398-020-0697-x.

0

0

0

PUBMED

Enhancing cognitive training effects in Alzheimer's disease: rTMS as an add-on treatment

Bagattini C, Zanni M, Barocco F, Caffarra P, Brignani D, Miniussi C, Defanti CA.

Brain Stimul. 2020 Nov-Dec;13(6):1655-1664. doi: 10.1016/j.brs.2020.09.010. Epub 2020 Sep 28.

0

0

0

PUBMED

Nrf2: a dark horse in Alzheimer's disease treatment

Osama A, Zhang J, Yao J, Yao X, Fang J.

Ageing Res Rev. 2020 Dec;64:101206. doi: 10.1016/j.arr.2020.101206. Epub 2020 Nov 2.

0

0

0

PUBMED

Preclinical Alzheimer Disease Drug Development: Early Considerations Based on Phase 3 Clinical Trials

Hung A, Schneider M, Lopez MH, McClellan M.

J Manag Care Spec Pharm. 2020 Jul;26(7):888-900. doi: 10.18553/jmcp.2020.26.7.888.

0

0

0

PUBMED

Heat therapy: possible benefits for cognitive function and the aging brain

Von Schulze AT, Deng F, Morris JK, Geiger PC.

J Appl Physiol (1985). 2020 Dec 1;129(6):1468-1476. doi: 10.1152/japplphysiol.00168.2020. Epub 2020 Sep 24.

0

0

0

PUBMED

Research Progress on Alzheimer's Disease and Resveratrol

Yan Y, Yang H, Xie Y, Ding Y, Kong D, Yu H.

Neurochem Res. 2020 May;45(5):989-1006. doi: 10.1007/s11064-020-03007-0. Epub 2020 Mar 11.

0

0

0

PUBMED

Immunotherapy for Parkinson's disease

Schwab AD, Thurston MJ, Machhi J, Olson KE, Namminga KL, Gendelman HE, Mosley RL.

Neurobiol Dis. 2020 Apr;137:104760. doi: 10.1016/j.nbd.2020.104760. Epub 2020 Jan 21.

0

0

0

PUBMED

Management of cognitive decline in Alzheimer's disease using a non-pharmacological intervention program: A case report

Quail Z, Carter MM, Wei A, Li X.

Medicine (Baltimore). 2020 May 22;99(21):e20128. doi: 10.1097/MD.0000000000020128.

0

0

0

PUBMED

Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases

Guo R, Li L, Su J, Li S, Duncan SE, Liu Z, Fan G.

Drug Des Devel Ther. 2020 Nov 5;14:4735-4748. doi: 10.2147/DDDT.S266911. eCollection 2020.

0

0

0

PUBMED

Anticoagulants for Treatment of Alzheimer's Disease

Grossmann K.

J Alzheimers Dis. 2020;77(4):1373-1382. doi: 10.3233/JAD-200610.

0

0

0

PUBMED

A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer's Disease

Ettcheto M, Busquets O, Espinosa-Jiménez T, Verdaguer E, Auladell C, Camins A.

Curr Pharm Des. 2020;26(12):1286-1299. doi: 10.2174/1381612826666200211121416.

0

0

0

PUBMED

Photobiomodulation for Alzheimer's Disease: Translating Basic Research to Clinical Application

Enengl J, Hamblin MR, Dungel P.

J Alzheimers Dis. 2020;75(4):1073-1082. doi: 10.3233/JAD-191210.

0

0

0

PUBMED

Meta-analysis of Ginkgo biloba Preparation for the Treatment of Alzheimer's Disease

Liao Z, Cheng L, Li X, Zhang M, Wang S, Huo R.

Clin Neuropharmacol. 2020 Jul/Aug;43(4):93-99. doi: 10.1097/WNF.0000000000000394.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy